IPA questions FAERS data interpretation in the Ohio State University study
Express Pharma
MARCH 12, 2025
IPA also pointed out that US regulations require adverse events related to any dosage form of a drug to be reported under the same Abbreviated New Drug Application (ANDA) number, even if the product is manufactured at a different facility or outside India. Thus, it cannot be conclusively linked with the manufacturing site or manufacturers.
Let's personalize your content